IP Library Granted Patent US 11,717,682
Granted Patent B2
US 11,717,682 · App. 17/028,055 · Granted Aug 8, 2023

Apparatus and method for relieving pain using transcutaneous electrical nerve stimulation

Inventors: Shai N. Gozani (Newton, MA); Xuan Kong (Acton, MA); Andres Aguirre (Belmont, MA); Glenn Herb (Weston, MA); Marc Cryan (Maynard, MA); Michael Williams (Melrose, MA)
Assignee: NeuroMetrix, Inc
A61N1/36014A61N1/0456A61N1/0476A61N1/0492A61N1/321A61N1/36021A61N1/36034A61N1/37247A61N1/36031
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,717,682
App. No.
17/028,055
Granted
Aug 8, 2023
Kind
B2
Abstract

Apparatus for transcutaneous electrical nerve stimulation in humans, the apparatus comprising: a housing; a stimulation unit mounted within the housing for electrically stimulating nerves; an electrode array releasably mounted to the housing and connectable to the stimulation means, the electrode array comprising a plurality of electrodes for electrical stimulation of nerves; a control unit mounted to the housing and electrically connected to the stimulation unit for controlling at least one characteristic of the stimulation unit; a monitoring unit mounted to the housing and electrically connected to the stimulation unit for monitoring at least one characteristic of the stimulation unit; a user interface unit mounted to the housing and electrically connected to the control unit for controlling the stimulation unit; a display unit mounted to the housing and electrically connected to the control unit and the monitoring unit for displaying the status of the stimulations unit; and a strap attached to the housing; wherein the strap is configured to hold the housing, stimulation unit and electrode array at a specific anatomical location to treat pain.

Claims (42)

1. A method for setting the therapeutic stimulation intensity for transcutaneous electrical nerve stimulation in humans, the method comprising the steps of:

initiating a transcutaneous electrical nerve stimulation session for a user at a first therapeutic stimulation intensity;

automatically adjusting the first therapeutic stimulation intensity at a pre-determined adjustment rate, wherein the pre-determined adjustment rate is fixed during the transcutaneous electrical nerve stimulation session;

responding to commands from the user for manual changes in the therapeutic stimulation intensity;

continuing the transcutaneous electrical nerve stimulation session for a period of time; and

updating at least one of the first therapeutic stimulation intensity and the pre-determined adjustment rate for future transcutaneous electrical stimulation sessions based on accumulative changes initiated by the user.

2. A method according to claim 1 wherein the first therapeutic stimulation intensity is updated for future transcutaneous electrical stimulation sessions based on accumulative changes initiated by the user.

3. A method according to claim 1 wherein the pre-determined adjustment rate is updated for future transcutaneous electrical stimulation sessions based on accumulative changes initiated by the user.

4. A method according to claim 1 wherein the first therapeutic stimulation intensity and the pre-determined adjustment rate are both updated for future transcutaneous electrical stimulation sessions based on accumulative changes initiated by the user.

5. A method according to claim 1 wherein the first therapeutic stimulation intensity is determined automatically based on an electro-tactile sensation threshold indicated by the user.

6. A method according to claim 1 wherein the automatic intensity adjustment is to increase the intensity by a multiplicative factor at a time interval.

7. A method according to claim 6 wherein the time interval is one minute.

8. A method according to claim 6 wherein the multiplicative factor for future stimulation sessions is updated according to a target stimulation intensity level as projected by the multiplicative factor, an actual stimulation intensity level as modified by the user, and the difference between these intensity levels at the end of a current stimulation session.

9. A method according to claim 6 wherein the multiplicative factor is 1.004 and the time interval is 1 minute.

10. A method according to claim 1 wherein the automatic intensity adjustment is to increase the intensity by an additive factor at a time interval.

11. A method according to claim 1 wherein the period of time is the lesser of 60 minutes and a lower value due to a stimulation exit event.

12. A method according to claim 11 wherein the stimulation exit event is triggered by a user action.

13. A method according to claim 11 wherein the stimulation exit event is triggered by a stimulation error condition.

14. A method for setting the therapeutic stimulation intensity for transcutaneous electrical nerve stimulation in humans, the method comprising the steps of:

initiating transcutaneous electrical nerve stimulation to a user at a first therapeutic stimulation intensity;

automatically adjusting the therapeutic stimulation intensity at a pre-determined adjustment rate;

responding to commands from the user for manual changes in the therapeutic stimulation intensity;

continuing the transcutaneous electrical nerve stimulation for a period of time; and

updating at least one of the first therapeutic stimulation intensity and the pre-determined adjustment rate for future electrical stimulation sessions based on accumulative changes initiated by the user;

wherein the first therapeutic stimulation intensity is determined automatically based on an electro-tactile sensation threshold indicated by the user.

15. A method for setting the therapeutic stimulation intensity for transcutaneous electrical nerve stimulation in humans, the method comprising the steps of:

initiating transcutaneous electrical nerve stimulation to a user at a first therapeutic stimulation intensity;

automatically adjusting the therapeutic stimulation intensity at a pre-determined adjustment rate;

responding to commands from the user for manual changes in the therapeutic stimulation intensity;

continuing the transcutaneous electrical nerve stimulation for a period of time; and

updating at least one of the first therapeutic stimulation intensity and the pre-determined adjustment rate for future electrical stimulation sessions based on accumulative changes initiated by the user;

wherein the automatic intensity adjustment is to increase the intensity by a multiplicative factor at a time interval.

16. A method according to claim 15 wherein the time interval is one minute.

17. A method according to claim 15 wherein the multiplicative factor for future stimulation sessions is updated according to a target stimulation intensity level as projected by the multiplicative factor, an actual stimulation intensity level as modified by the user, and the difference between these intensity levels at the end of a current stimulation session.

18. A method according to claim 15 wherein the multiplicative factor is 1.004 and the time interval is 1 minute.

19. A method for setting the therapeutic stimulation intensity for transcutaneous electrical nerve stimulation in humans, the method comprising the steps of:

initiating transcutaneous electrical nerve stimulation to a user at a first therapeutic stimulation intensity;

automatically adjusting the therapeutic stimulation intensity at a pre-determined adjustment rate;

responding to commands from the user for manual changes in the therapeutic stimulation intensity;

continuing the transcutaneous electrical nerve stimulation for a period of time; and

updating at least one of the first therapeutic stimulation intensity and the pre-determined adjustment rate for future electrical stimulation sessions based on accumulative changes initiated by the user;

wherein the automatic intensity adjustment is to increase the intensity by an additive factor at a time interval.

Assignments (1)
SECURITY INTEREST Recorded Aug 12, 2025
From: NEUROMETRIX, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND II, L.P.
Reel/Frame 072450/0668 →
Cited By (3)
US 12,551,699 US 12,575,780 US 12,629,522